Author(s): Mohamed Zerein Fathima, T.S. Shanmugarajan, S. Satheesh Kumar, B.V.Venkata Nagarjuna Yadav
DOI: 10.5958/0974-360X.2017.00053.1
Views:
71
(pdf),
2838
(html)
Access:
Open Access
Cite: Mohamed Zerein Fathima, T.S. Shanmugarajan, S. Satheesh Kumar, B.V.Venkata Nagarjuna Yadav. Comparative in Silico Docking Studies of Hinokitiol with Sorafenib and Nilotinib against Proto-Oncogene Tyrosine-Protein Kinase(ABL1) and Mitogen-activated Protein Kinase (MAPK) to Target Hepatocellular Carcinoma. Research J. Pharm. and Tech. 2017; 10(1): 257-262. doi: 10.5958/0974-360X.2017.00053.1
Read More